These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 29397899

  • 21. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS, Ahn YM, Park HJ, Lee KY, Kim SH, Kang UG, Kim YS.
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [Abstract] [Full Text] [Related]

  • 22. Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
    Behdani F, Hebrani P, Rezaei Ardani A, Rafee E.
    Arch Iran Med; 2011 Jul; 14(4):270-5. PubMed ID: 21726104
    [Abstract] [Full Text] [Related]

  • 23. Add-On Pregnenolone with L-Theanine to Antipsychotic Therapy Relieves Negative and Anxiety Symptoms of Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Kardashev A, Ratner Y, Ritsner MS.
    Clin Schizophr Relat Psychoses; 2018 Jul; 12(1):31-41. PubMed ID: 26218236
    [Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [Abstract] [Full Text] [Related]

  • 25. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
    Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G.
    Biol Psychiatry; 2006 Sep 15; 60(6):645-9. PubMed ID: 16780811
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Davidson M, Saoud J, Staner C, Noel N, Luthringer E, Werner S, Reilly J, Schaffhauser JY, Rabinowitz J, Weiser M, Luthringer R.
    Am J Psychiatry; 2017 Dec 01; 174(12):1195-1202. PubMed ID: 28750582
    [Abstract] [Full Text] [Related]

  • 27. Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.
    Baker A, Clarke L, Donovan P, P J Ungerer J, Hartel G, Bruxner G, Cocchi L, Gordon A, Moudgil V, Robinson G, Roy D, Sohal R, Whittle E, Scott JG.
    Trials; 2021 Dec 13; 22(1):918. PubMed ID: 34903265
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.
    J Clin Psychiatry; 2007 Mar 13; 68(3):368-79. PubMed ID: 17388705
    [Abstract] [Full Text] [Related]

  • 31. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
    Evins AE, Fitzgerald SM, Wine L, Rosselli R, Goff DC.
    Am J Psychiatry; 2000 May 13; 157(5):826-8. PubMed ID: 10784481
    [Abstract] [Full Text] [Related]

  • 32. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group.
    N Engl J Med; 2006 Feb 02; 354(5):472-82. PubMed ID: 16452559
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine: A Randomized, Double-Blind, Placebo-controlled Clinical Trial.
    Krivoy A, Onn R, Vilner Y, Hochman E, Weizman S, Paz A, Hess S, Sagy R, Kimhi-Nesher S, Kalter E, Friedman T, Friedman Z, Bormant G, Trommer S, Valevski A, Weizman A.
    EBioMedicine; 2017 Dec 02; 26():138-145. PubMed ID: 29226809
    [Abstract] [Full Text] [Related]

  • 35. Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials.
    Goff DC, Keefe R, Citrome L, Davy K, Krystal JH, Large C, Thompson TR, Volavka J, Webster EL.
    J Clin Psychopharmacol; 2007 Dec 02; 27(6):582-9. PubMed ID: 18004124
    [Abstract] [Full Text] [Related]

  • 36. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR.
    JAMA Psychiatry; 2016 Sep 01; 73(9):947-54. PubMed ID: 27438995
    [Abstract] [Full Text] [Related]

  • 37. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M, Levi L, Burshtein S, Hagin M, Matei VP, Podea D, Micluția I, Tiugan A, Păcală B, Grecu IG, Noy A, Zamora D, Davis JM.
    J Clin Psychiatry; 2017 Jul 01; 78(7):e758-e765. PubMed ID: 28541645
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial.
    Ryan A, Baker A, Dark F, Foley S, Gordon A, Hatherill S, Stathis S, Saha S, Bruxner G, Beckman M, Richardson D, Berk M, Dean O, McGrath J, Group CW, Scott J.
    Trials; 2017 Apr 07; 18(1):165. PubMed ID: 28388932
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.